Research analysts at StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a report released on Sunday. The firm set a “hold” rating on the software maker’s stock.
Veradigm Price Performance
Shares of NASDAQ:MDRX opened at $10.66 on Friday. The company’s fifty day moving average is $9.62 and its two-hundred day moving average is $9.33. Veradigm has a 1-year low of $5.01 and a 1-year high of $12.86.
Hedge Funds Weigh In On Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC purchased a new position in Veradigm Inc. (NASDAQ:MDRX – Free Report) in the second quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Stories
- Five stocks we like better than Veradigm
- What is the Australian Securities Exchange (ASX)
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- What is the Euro STOXX 50 Index?
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Time to Load Up on Home Builders?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
